_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
Partnered by:
Associate Partners:
My Account
Partnered by:
Associate Partners:
Partnered by:
Associate Partners:
BSE Live
Jan 22, 15:40Prev. Close
295.90
Open Price
301.15
Bid Price (Qty.)
278.00 (7)
Offer Price (Qty.)
289.90 (50)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Nine Months Results of Coral Laboratories (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 50.03 | 71.79 | 65.77 | 61.29 | 50.11 | |
| Other Operating Income | -- | -- | -- | 3.11 | 3.03 | |
| Total Income From Operations | 50.03 | 71.79 | 65.77 | 64.40 | 53.14 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 26.19 | 38.51 | 37.92 | 36.78 | 30.87 | |
| Purchase of Traded Goods | 3.88 | 1.22 | 0.98 | 0.77 | -- | |
| Increase/Decrease in Stocks | -0.95 | -0.27 | -1.76 | -3.63 | -0.46 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 6.98 | 7.13 | 6.02 | 4.79 | 3.58 | |
| Depreciation | 1.55 | 1.46 | 1.15 | 1.31 | 1.41 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 10.80 | 11.48 | 10.34 | 8.31 | 7.14 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1.57 | 12.25 | 11.11 | 16.05 | 10.59 | |
| Other Income | 2.80 | 4.19 | 2.23 | 2.48 | 1.60 | |
| P/L Before Int., Excpt. Items & Tax | 4.37 | 16.44 | 13.34 | 18.54 | 12.19 | |
| Interest | 0.03 | 0.00 | 0.01 | 0.03 | 0.06 | |
| P/L Before Exceptional Items & Tax | 4.34 | 16.44 | 13.33 | 18.51 | 12.13 | |
| Exceptional Items | -- | -- | -- | -- | -- | |
| P/L Before Tax | 4.34 | 16.44 | 13.33 | 18.51 | 12.13 | |
| Tax | 0.70 | 5.04 | 3.87 | 6.46 | 3.40 | |
| P/L After Tax from Ordinary Activities | 3.64 | 11.40 | 9.46 | 12.05 | 8.73 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 3.64 | 11.40 | 9.46 | 12.05 | 8.73 | |
| Equity Share Capital | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 10.20 | 31.92 | 26.49 | 33.72 | 24.43 | |
| Diluted EPS | 10.20 | 31.92 | 26.49 | 33.72 | 24.43 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 10.20 | 31.92 | 26.49 | 33.72 | 24.43 | |
| Diluted EPS. | 10.20 | 31.92 | 26.49 | 33.72 | 24.43 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- |
05.02.2019
Coral Labs Standalone December 2018 Net Sales at Rs 23.46 crore, up 14.49% Y-o-Y
01.11.2018
Coral Labs Standalone September 2018 Net Sales at Rs 25.65 crore, down 10.04% Q-o-Q
31.10.2018
Coral Labs Standalone September 2018 Net Sales at Rs 25.65 crore, down 10.04% Q-o-Q
17.03.2016
14 more drug majors get HC relief from Centre ban on FDC meds
